Elixxer Ltd - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Elixxer Ltd (ELXR) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Elixxer Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$2.81 Million

≈ $2.03 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2023)

This chart shows how Elixxer Ltd's Asset Resilience Ratio has changed over time. See Elixxer Ltd balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Elixxer Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Elixxer Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Elixxer Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Elixxer Ltd Industry Peers by Asset Resilience Ratio

Compare Elixxer Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Elixxer Ltd (2017–2023)

The table below shows the annual Asset Resilience Ratio data for Elixxer Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CA$0.00 ≈ $0.00	CA$2.81 Million ≈ $2.03 Million	--
2022-12-31	44.82%	CA$2.41 Million ≈ $1.74 Million	CA$5.37 Million ≈ $3.88 Million	-34.09pp
2021-12-31	78.91%	CA$13.28 Million ≈ $9.61 Million	CA$16.84 Million ≈ $12.18 Million	--
2020-12-31	0.00%	CA$0.00 ≈ $0.00	CA$20.81 Million ≈ $15.06 Million	--
2018-12-31	0.00%	CA$0.00 ≈ $0.00	CA$20.74 Million ≈ $15.00 Million	--
2017-12-31	24.65%	CA$677.24K ≈ $489.91K	CA$2.75 Million ≈ $1.99 Million	--

pp = percentage points

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic

Market Cap

$287.08K

CA$396.86K CAD

Market Cap Rank

#31021 Global

#1669 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$1.15

All Time High

CA$99.00